TCS
ALXN

Texas Children's’s Alexion Pharmaceuticals ALXN Stock Holding History

Texas Children's’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,389
Closed -$999K – 21
2019
Q1 		$999K Sell
7,389
-1,787
-19% -$222K 1.21% 10
2018
Q4 		$893K Buy
+9,176
New +$1.08M 1.25% 11

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Texas Children's's ALXN Position: Q2 2019 in Review

Texas Children's sold out of Alexion Pharmaceuticals (ALXN) in Q2 2019, closing a stake of 7,389 shares — an estimated $999K sold.

Texas Children's first reported a position in ALXN in Q4 2018 and held it in 2 quarters. The position peaked at $999K in Q1 2019. 636 funds tracked by Wall St. Rank hold ALXN as of Q2 2019.

  • Texas Children's reported no remaining Alexion Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Texas Children's sold 7,389 Alexion Pharmaceuticals shares in Q2 2019, an estimated $999K.
  • Texas Children's first reported a position in Alexion Pharmaceuticals in Q4 2018 and held it in 2 quarters.
  • Texas Children's's Alexion Pharmaceuticals position peaked at $999K in Q1 2019.
  • 636 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2019.

Based on Texas Children's's 13F filing for Q2 2019, filed 13 Aug 2019.